QEV-817

· Quivive Pharma, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for QEV-817, covering 2024-09-05 to 2026-08-05. Get the full timeline:

Most recent: Clinical Trial Results: Study to Investigate the Safety, Tolerability and Pharmacokinetics of QEV-817 Oral Suspension [Phase 1]